UPDATE 1-Bayer sells assets, cuts jobs, takes impairment charge

Bayer, the German drugmaker that bought U.S. seed company Monsanto, on Thursday announced the sale of a number of businesses, job cuts affecting 10 percent of its staff and 3.3 billion euros ($3.8 billion) in impairments.